Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada
Open Access
- 21 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (5)
Abstract
Atrial fibrillation (AF) is the most common cardiac rhythm disorder. Emerging evidence supporting the efficacy of catheter ablation in managing AF has led to increased demand for this therapy, potentially outpacing the capacity to perform this procedure. Mismatch between demand and capacity for AF ablation results in wait-times which have not been comprehensively evaluated at a population level. Additionally, the consequences of such delays in AF ablation, namely the risk of hospitalization or adverse events, have not been studied. This observational cohort study included adults referred for catheter ablation to treat AF in Ontario, Canada, between 1 April 2016 and 31 March 2020. Wait-time was defined from referral to the earliest of ablation, death, off-list, or the study endpoint of 31 March 2022. The outcomes of interest included a composite of death, hospitalization for AF/heart failure, and emergency department visit for AF/heart failure. Our study cohort included 6253 patients referred for de novo AF ablation. The median wait-time for patients who received and who did not receive ablation was 218 days (IQR: 112–363) and 520 days (IQR: 270–763), respectively. Wait-time increased consistently for patients referred between October 2017 and March 2020. Mortality was rare, but significant morbidity was observed, affecting 19.2% of patients on the waitlist for AF ablation. Paroxysmal AF was associated with a statistically significant greater risk for adverse outcomes on the waitlist (HR 1.51, 95% CI 1.18–1.93). Wait-times for AF ablation are increasing and are associated with significant morbidity.Keywords
Funding Information
- Jack Tu Chair in Cardiovascular Outcomes Research
- University of Toronto
- Canada Research Chair in Structural Heart Disease
This publication has 33 references indexed in Scilit:
- Catheter Ablation for Atrial Fibrillation with Heart FailureNew England Journal of Medicine, 2018
- National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999–2013Circulation, 2017
- Diagnosis-to-ablation time as a predictor of success: early choice for pulmonary vein isolation and long-term outcome in atrial fibrillation: results from the Middelheim-PVI RegistryEP Europace, 2017
- Identifying Patients With Atrial Fibrillation in Administrative DataCanadian Journal of Cardiology, 2016
- Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities StudyJournal of the American Heart Association, 2014
- Atrial Fibrillation and the Risk of Myocardial InfarctionJAMA Internal Medicine, 2014
- All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control studyEuropean Heart Journal, 2013
- Progression From Paroxysmal to Persistent Atrial FibrillationJACC, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998